Response to: 'Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered'. | LitMetric

A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Response to: 'Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered'. | LitMetric

Response to: 'Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered'.

Elio Novembre Mariannita Gelsomino Lucia Liotti Simona Barni Francesca Mori Mattia Giovannini Carla Mastrorilli Luca Pecoraro Francesca Saretta Riccardo Castagnoli Stefania Arasi Lucia Caminiti Angela Klain Michele Miraglia Del Giudice

Ital J Pediatr

Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, 80138, Italy.

Published: November 2024

Download full-text PDF
Source

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11550513 PMC
http://dx.doi.org/10.1186/s13052-024-01815-6 DOI Listing

Publication Analysis

Top Keywords

response 'failed

4

'failed oral

4

oral immunotherapy

4

immunotherapy considered

4

considered risk

4

risk factor

4

factor fatal

4

fatal anaphylaxis

4

anaphylaxis omalizumab

4

omalizumab treatment

4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!